Cove Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.24M Buy
12,372
+22
+0.2% +$5.64K 0.57% 34
2026
Q2
$3.11M Buy
12,350
+155
+1% +$33.3K 0.6% 32
2026
Q1
$2.65M Buy
12,195
+1,064
+10% +$236K 0.6% 31
2025
Q4
$2.54M Buy
11,131
+1,220
+12% +$278K 0.76% 31
2025
Q3
$2.29M Hold
9,911
– – 0.73% 31
2025
Q2
$1.84M Buy
9,911
+6,254
+171% +$1.16M 0.65% 36
2025
Q1
$766K Buy
3,657
+784
+27% +$152K 0.4% 66
2024
Q4
$511K Buy
2,873
+123
+4% +$22.6K 0.31% 67
2024
Q3
$543K Hold
2,750
– – 0.42% 56
2024
Q2
$472K Hold
2,750
– – 0.38% 59
2024
Q1
$501K Hold
2,750
– – 0.43% 56
2023
Q4
$426K Buy
+2,750
New +$401K 0.4% 58

Other funds holding ABBV

Cove Private Wealth's ABBV Position: Q3 2026 in Review

Cove Private Wealth increased its AbbVie (ABBV) stake by 0.18% in Q3 2026, buying an estimated $5.64K and bringing the position to 12,372 shares worth $3.24M. The position accounts for 0.57% of the portfolio, ranked #34.

Cove Private Wealth first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Cove Private Wealth held 12,372 shares of AbbVie worth $3.24M as of Q3 2026.
  • Cove Private Wealth bought 22 AbbVie shares in Q3 2026, an estimated $5.64K.
  • AbbVie made up 0.57% of Cove Private Wealth's portfolio in Q3 2026, its #34 holding.
  • Cove Private Wealth first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cove Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.